Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Featured
Featured posts
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #206: Q2’25 Psychedelic Lobbying; Tabernanthalog’s Neuroplasticity Pathway; UK Moves to Ease Schedule I Research Restrictions
GLP-1 Drugs, Psilocybin Mushrooms, and the Case for Sublingual Psilocin
Therapy or Threat? UK Expert Warns of Rising Ketamine Addiction as Phase III Alcoholism Trial Launches
The Psychedelic News Feed: January 5 – June 1, 2025
Pα+ Psychedelic Bulletin #205: AbbVie Eyes Gilgamesh; Psychedelics Use Increases in U.S.; FDA Moves to Ban Kraton Compound 7-OH; What Is Sinema Selling?
Mareesa Stertz & Tania Abdul – Sphinx Gate: Know Thyself at...
Psilocybin Enters German Psychiatry: A Clinical Milestone for Mental Health
Alan Davis – Psychedelic Research and Patient Safety at Ohio State...
Chad Charles – Integrating 5-MeO-DMT: Therapy, Harm Reduction, and Best Practices
Germany Establishes EU’s First Psilocybin Compassionate Access Program
Chad Charles – Integrating 5-MeO-DMT: Therapy, Harm Reduction, and Best Practices
Dispatch: The Neurobiology of Psychedelics Gordon Research Conference — Circuitry, Consciousness,...
William Leonard Pickard interviews Bryan Hubbard about the new policy frontier...
Pα+ Psychedelic Bulletin #204: FDA Keeps GH Research’s 5-MeO-DMT on Ice;...
June 2025 Psychedelic Patent Update
1
2
3
...
294
Page 1 of 294
